Sarah De Clercq
- Molecular Biology top 10%
- Oncology top 5%
- Neurology top 5%
- Cancer Research top 10%
- Infectious Diseases top 10%
- Co-authors
- Jean‐Christophe MarineEric BellefroidMarion MaetensSarah FrancozPascal FromentGilles DoumontSven BogaertsGeertrui Denecker
- Topics
- Cancer-related Molecular Pathways (8 papers)Pancreatic and Hepatic Oncology Research (6 papers)Cancer Research and Treatments (4 papers)
- Cited by
- OncologyNeurologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Clinical Oncology
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Sarah De Clercq
28 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 867
- Oncology 591
- Neurology 227
- Cancer Research 190
- Infectious Diseases 165
Countries citing papers authored by Sarah De Clercq
This map shows the geographic impact of Sarah De Clercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah De Clercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah De Clercq more than expected).
Fields of papers citing papers by Sarah De Clercq
This network shows the impact of papers produced by Sarah De Clercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah De Clercq. The network helps show where Sarah De Clercq may publish in the future.
Co-authorship network of co-authors of Sarah De Clercq
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah De Clercq. A scholar is included among the top collaborators of Sarah De Clercq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah De Clercq. Sarah De Clercq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 15 | |
| 3 | 18 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 191 | |
| 7 | 20 | |
| 8 | 26 | |
| 9 | 50 | |
| 10 | 45 | |
| 11 | 40 | |
| 12 | 61 | |
| 13 | 199 | |
| 14 | 49 | |
| 15 | 29 | |
| 16 | 91 | |
| 17 | Real-time qPCR as a tool for evaluating RNAi-mediated gene silencing | 1 |
| 18 | 120 | |
| 19 | 55 | |
| 20 | 210 |
About Sarah De Clercq
Sarah De Clercq is a scholar working on Oncology, Biotechnology and Neurology, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (591 citations), Neurology (227 citations) and Cancer Research (190 citations). Sarah De Clercq has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Jean‐Christophe Marine, Eric Bellefroid, Marion Maetens, Sarah Francoz, Pascal Froment, Gilles Doumont, Sven Bogaerts, Geertrui Denecker, Isabelle Salmon and Panagiota A. Sotiropoulou. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.